THAZ
| Clinical data | |
|---|---|
| Drug class | GABAA-ρ receptor antagonist; GABAA receptor antagonist; Glycine receptor antagonist |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C7H10N2O2 |
| Molar mass | 154.169 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
THAZ, also known as 5,6,7,8-tetrahydro-4H-isoxazolo(4,5-d)azepin-3-ol, is a moderately potent GABAA-ρ receptor antagonist related to gaboxadol (THIP).[1][2] Unlike gaboxadol, it is said to be virtually inactive at the GABAA receptor.[1] However, in other studies, it showed significant affinity for the GABAA receptor, where it appeared to act as an antagonist.[2][3] In addition to its GABAA-ρ receptor antagonism, THAZ is a very weak glycine receptor antagonist.[2][4] In contrast to muscimol and gaboxadol, THAZ injected directly into the brain produced convulsions.[3] The drug was first described in the scientific literature by Povl Krogsgaard-Larsen and colleagues by 1979.[3] Derivatives of THAZ such as N-Bn-THAZ and O-Bn-THAZ have been found to act as serotonin 5-HT2A and 5-HT2C receptor agonists.[5][6]
See also
References
- ^ a b Frølund B, Ebert B, Kristiansen U, Liljefors T, Krogsgaard-Larsen P (August 2002). "GABA(A) receptor ligands and their therapeutic potentials". Current Topics in Medicinal Chemistry. 2 (8): 817–832. doi:10.2174/1568026023393525. PMID 12171573.
Like thio-THIP, the structurally related THIP analogues, aza-THIP, iso-THIP and THAZ (Fig. 4) are virtually inactive at the GABAA receptors [51, 52], but disclose antagonistic effects at the GABAC receptors [53].
- ^ a b c Krehan D, Frølund B, Ebert B, Nielsen B, Krogsgaard-Larsen P, Johnston GA, et al. (November 2003). "Aza-THIP and related analogues of THIP as GABA C antagonists". Bioorganic & Medicinal Chemistry. 11 (23): 4891–4896. doi:10.1016/j.bmc.2003.09.016. PMID 14604650.
- ^ a b c Arnt J, Krogsgaard-Larsen P (November 1979). "GABA agonists and potential antagonists related to muscimol". Brain Research. 177 (2): 395–400. doi:10.1016/0006-8993(79)90793-5. PMID 227538.
- ^ Krogsgaard-Larsen P, Hjeds H, Curtis DR, Leah JD, Peet MJ (November 1982). "Glycine antagonists structurally related to muscimol, THIP, or isoguvacine". Journal of Neurochemistry. 39 (5): 1319–1324. doi:10.1111/j.1471-4159.1982.tb12573.x. PMID 6288870.
- ^ Duan W, Cao D, Wang S, Cheng J (January 2024). "Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants". Chemical Reviews. 124 (1): 124–163. doi:10.1021/acs.chemrev.3c00375. PMID 38033123.
- ^ Jensen AA, Plath N, Pedersen MH, Isberg V, Krall J, Wellendorph P, et al. (February 2013). "Design, synthesis, and pharmacological characterization of N- and O-substituted 5,6,7,8-tetrahydro-4H-isoxazolo[4,5-d]azepin-3-ol analogues: novel 5-HT(2A)/5-HT(2C) receptor agonists with pro-cognitive properties". Journal of Medicinal Chemistry. 56 (3): 1211–1227. doi:10.1021/jm301656h. PMID 23301527.
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.